Azstarys

Azstarys specifically contain serdexmethylphenidate, a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate. Azstarys is a central nervous system (CNS) stimulant prescription medication used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. This medicine may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.

Recommended Dosage: Administer the proposed dosage orally (by mouth) once daily in the morning with or without food. Azstarys capsules may be swallowed whole or opened and the existing contents sprinkled into water (50mL) or over 2 tablespoons of applesauce. Consume all the medicine/food mixture promptly or within 10 minutes of mixing; avoid storing for future use.

Pediatric Patients 6-12 Years of Age: The recommended starting dosage of Azstarys is 39.2 mg serdexmethylphenidate/ 7.8 mg dexmethylphenidate once daily in the morning. The dosage can be increased after 1 week to a dosage of 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate per day, or decreased after one week to a dosage of 26.1 mg serdexmethylphenidate/5.2 mg dexmethylphenidate daily, on behalf of response and tolerability. The maximum recommended dosage is 52.3 mg serdexmethylphendiate/10.4 mg dexmethyphenidate once daily.

Adults and Pediatric Patients 13-17 Years of Age: The recommended starting dosage of Azstarys is 39.2 mg serdexmethylphenidate/7.8 mg dexmethylphenidate once daily in the morning. The dosage can be increased after 1 week to a dosage of 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate daily. The maximum recommended dosage is 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily.

Pharmacological treatment of Attention Deficit Hyperactivity Disorder may be required for an extended time span. Periodically reevaluate the long-term use of this (Azstarys) treatment, and adjust dosage as required.  

• CNS stimulants, including medicine Azstarys, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Evalute the probability of abuse before prescribing, and monitor for signs/symptoms of abuse and dependence while on therapy.
• Sudden death, ainfarction and stroke may be reported in adults with CNS stimulant treatment at recommended doses. Avoid use in those with serious heart rhythm abnormalities, known structural cardiac abnormalities, cardiomyopathy, coronary artery disease, and other serious heart complications. Further assess those who develop unexplained syncope, exertional chest pain, or arrhythmias during treatment.
• CNS stimulants may cause an increase in blood pressure (mean increase around 2-4 mmHg) and heart rate (mean increase around 3-6 beats per minute). Individuals may have greater increases. Evaluate all respective patients for hypertension as well as tachycardia.
• CNS stimulants may be responsible for inducing a manic or mixed mood episode in patients. Before starting treatment, screen patients for potential for establishing a manic episode (e.g., comorbid or a family history of suicide, depression, or bipolar disorder).
• CNS stimulants for ADHD, including Azstarys, are linked with peripheral vasculopathy, including Raynaud’s phenomenon. Precise observation for digital changes is crucial during therapy with ADHD stimulants. Further clinical assessment (rheumatology referral) may be apt for certain patients.
• CNS stimulants may be responsible for weight loss and slowing of growth rate in pediatric patients. Precisely monitor growth (weight as well as  height) in pediatric patients treated with CNS stimulants, including Azstarys. Those who are not growing or gaining height or weight as required may need to have their therapy interrupted.

What documents are required to import AZSTARYS to India?

AZSTARYS (Serdexmethylphenidate and Dexmethylphenidate) capsules can be imported by patients or government hospitals on the name of the patients only. 

The following documentation required to import the product:

• Valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients Identity Proof (issued by government of India)

How does order be confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription of Doctor
• Import permit if applicable

Is AZSTARYS available in India?

AZSTARYS (serdexmethylphenidate and dexmethylphenidate capsule) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input

• On availability of Azstarys in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
• Medicine Price.
• Finding Genuine and reliable source from Canada, Europe, USA and Australia
• Ensuring 100% transparency.

AZSTARYS can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.

IPN (Indian Pharma Network) can facilitate the supply of AZSTARYS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Azstarys price in India . 

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

What is the Generic Name for the trade name drug Azstarys®?

Serdexmethylphenidate/Dexmethylphenidate is Generic Name for the trade name drug Azstarys®.

What is the Manufacturer Name of Azstarys®?

Azstarys® is manufactured by KemPharm, Inc.

Is Azstarys® approved by the FDA?

Yes, Azstarys® is approved by the FDA. Date of approval: March 2, 2021.

What is the dosage and form of Azstarys® supplied?

Azstarys® is supplied as Capsules (serdexmethylphenidate/dexmethylphenidate): 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg for oral administration. 

Where can I get Azstarys® 26.1 mg capsule at the best price in India?

To get the best azstarys 26.1 mg Capsules price in India, kindly contact Indian Pharma Network (a WHO GDP & ISO 9001 : 2008 certified company). For Azstarys, a valid medical prescription is required from your treating physician. 

What are the most common side effects with Azstarys®? 

The most common side effects with Azstarys® are: insomnia, nausea, appetite decreased, blood pressure increased, vomiting, weight decreased, dyspepsia, abdominal pain, anxiety, dizziness, irritability, affect lability, and tachycardia.

How much does Azstarys® cost in India?

The cost of Azstarys in India is less and can vary. In order to procure this ADHD medication authentically, one can Call/WhatsApp: +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Azstarys®?

Store at temperature 20-25°C (68-77°F); excursions permitted between 15-30°C (59-86°F). Protect the capsules from moisture. Dispense in well tight container.

Is it safe to buy Azstarys® capsules online from India?

Yes, you can buy azstarys capsules online at best price from the Indian Pharma Network (IPN) if Azstarys (Serdexmethylphenidate/Dexmethylphenidate) has not been approved or is not available in your home country. 

What are the Highlights of prescribing information for Azstarys®?

Click Here to download full Azstarys prescribing information.